ADAR1 Capital Management »

Regenxbio Inc equity us cm shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Regenxbio Inc equity us cm (RGNX) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Regenxbio Inc equity us cm

Tip: Access up to 7 years of quarterly data

All positions including Regenxbio Inc equity us cm held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regenxbio Inc equity us cm by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $53k 2.5k 21.07

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Regenxbio Inc equity us cm

BlackRock
BlackRock
Vanguard Group
Redmile Group
State Street Corporation
Jpmorgan Chase & Co
Morgan Stanley
Dimensional Fund Advisors
Avidity Partners Management
Geode Capital Management
Aquilo Capital Management
Balyasny Asset Management
Goldman Sachs Group
Assenagon Asset Management
MPM Oncology Impact Management

View all funds holding Regenxbio Inc equity us cm